Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Stomach Neoplasms 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Parathyroid Diseases 1Ovarian Neoplasms 1Osteosarcoma 1Neuroma 1Neoplasms 1Lymphatic Metastasis 1Hypoparathyroidism 1Graves Disease 1Goiter 1Giant Cell Tumor of Tendon Sheath 1Giant Cell Tumor of Bone 1Erectile Dysfunction 1Endometrial Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Anastomotic Leak 1Adenoma 1

Interventions

anlotinib 1Tranexamic Acid 1Indocyanine Green 1Ifosfamide 1Hyperbaric Oxygenation 1Enoxaparin 1Doxorubicin 1Brachytherapy 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Sarcoma × Indocyanine Green × Clear all
NCT04854018 2023-08-14

Indo-cyanine Green (ICG) in Paediatric Oncology MIS

Birmingham Women's and Children's NHS Foundation Trust

Phase 4 Completed
20 enrolled
Sarcoma

Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡